These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 5028221)

  • 1. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 5. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 10. The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.
    Johansen K; Orskov H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):709-15. PubMed ID: 4678208
    [No Abstract]   [Full Text] [Related]  

  • 11. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 12. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
    Vague P; Depieds R; Boeuf G; Leroy C; Perrimond D; Codaccioni JL; Vague J
    Ann Endocrinol (Paris); 1966; 27(6):820-9. PubMed ID: 5973133
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic cirrhosis (non hemochromatosic) Diabetes mellitus. III. Secretion of insulin in cirrhotic patients tolerant and non tolerant to oral glucose overload].
    Cerdán Vallejo A; Jolin Buzo T; Sánchez Franco F; Ortíz Vázquez J
    Rev Clin Esp; 1974 Sep; 134(5):441-8. PubMed ID: 4438739
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin secretion during the early stages of diabetes (results of our experience)].
    Serrano-Rios M; Ramos F; Vivanco F; Rodriguez-Minon JL
    Cah Med; 1973 Oct; 14(11):913-21. PubMed ID: 4789098
    [No Abstract]   [Full Text] [Related]  

  • 18. Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes.
    Varsano-Aharon N; Echemendia E; Yalow RS; Berson SA
    Metabolism; 1970 Jun; 19(6):409-17. PubMed ID: 5444245
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P; Kewitz H; Schnapperelle U
    Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
    [No Abstract]   [Full Text] [Related]  

  • 20. Immediate but not long-term administration of nicardipine inhibits tolbutamide-induced insulin secretion from rat pancreatic beta cells.
    Liu CQ; Li XJ; Zhang W; Zhang HJ; Lin MZ; Yang SY
    Pancreas; 2010 May; 39(4):452-7. PubMed ID: 19959966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.